Market Overview:
The global transdermal gel market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in transdermal drug delivery systems. Based on type, the ionophoresis segment is expected to account for the largest share of the global transdermal gel market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period. The large share and high growth rate of this segment can be attributed to factors such as increased adoption of iontophoresis devices for pain management and increasing use of these devices for drug delivery purposes. Based on application, hospitals are expected to account for the largest share of the global transdermal gel market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period. The large share and high growth rate of this segment can be attributed various factors such as growing numberof hospital admissions owingto increase incidenceof chronic diseasesand rising demandfor better treatment options .
Product Definition:
A transdermal gel is a substance that is applied to the skin in order to deliver medication through the skin. The medication can be delivered directly to the bloodstream, which can provide faster and more consistent absorption than if it were taken orally. Transdermal gels are often used to treat conditions such as pain, inflammation, and anxiety.
Ionophoresis:
Ionophoresis is the movement of charged particles (ions) through a solution by collisions or Brownian motion. The process is named after the Greek word ionos, which means "salt" and phoresis, which means "to convey". In this technique, ions are moved in an electric field across a membrane to another solution on the other side of the membrane.
Electroporation:
Electroporation is the process of creating a small bubble of electricity in a solution which causes temporary cavitation and results in the rapid rise of particles. The rising gas particles are then captured by a filter to separate them from the solution. This method is used for producing micro-particles with sizes less than one micron, which are used as fillers in transdermal gels.
Application Insights:
The transdermal gel finds application in various fields including hospital, clinic, and others. In 2017, the other segment dominated the market with a share of over 80.0%. This can be attributed to growing awareness about new treatment options for various skin conditions along with increasing R&D investments by key industry players. For instance, in January 2018; Galderma Laboratories received FDA approval for its RenovaBio line of products that includes three types of transdermal creams namely;RenovaRetaille Transcutaneous Heating System (THS) device is used for the safe and effective delivery of energy through radiofrequency waves to damaged or distressed skin surfaces without the use of heat or electricity thereby minimizing exposure time as compared to conventional methods such as dermabrasion and laser treatments.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. North America has a large number of transdermal manufacturers and suppliers, which makes it an important regional segment for global markets.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels, increasing adoption of new technologies such as smartphones along with improved internet connectivity among people resulting in higher demand for medical products & services including dermal patches & ionophoresis systems.
The Latin American market was valued at USD X million in 2017.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for transdermal gels in the coming years.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as diabetes, cancer, and arthritis is on the rise globally, which is likely to boost the demand for transdermal gels in the near future.
- Growing awareness about benefits of transdermal gels: There has been a growing awareness about the benefits of using transdermal gels in recent years, which is likely to propel market growth over the forecast period.
- Technological advancements: The development of new and innovative technologies for manufacturing transdermal gel products is expected to create opportunities for market growth over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transdermal Gel Market Research Report
By Type
Ionophoresis, Electroporation, Sonophoresis
By Application
Hospital, Clinic, Other
By Companies
3M, Boehringer Ingelheim International, Mylan, Norvartis, GSK, Novel Pharmaceutical, LTS Lohmann, Johson & Johson, Bayer, Actavis, Corium
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Transdermal Gel Market Report Segments:
The global Transdermal Gel market is segmented on the basis of:
Types
Ionophoresis, Electroporation, Sonophoresis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M
- Boehringer Ingelheim International
- Mylan
- Norvartis
- GSK
- Novel Pharmaceutical
- LTS Lohmann
- Johson & Johson
- Bayer
- Actavis
- Corium
Highlights of The Transdermal Gel Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ionophoresis
- Electroporation
- Sonophoresis
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transdermal Gel Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A transdermal gel is a medication that is applied to the skin. It is a type of patch. Transdermal gels are used to treat pain, inflammation, and other conditions.
Some of the key players operating in the transdermal gel market are 3M, Boehringer Ingelheim International, Mylan, Norvartis, GSK, Novel Pharmaceutical, LTS Lohmann, Johson & Johson, Bayer, Actavis, Corium.
The transdermal gel market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transdermal Gel Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transdermal Gel Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transdermal Gel Market - Supply Chain
4.5. Global Transdermal Gel Market Forecast
4.5.1. Transdermal Gel Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transdermal Gel Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transdermal Gel Market Absolute $ Opportunity
5. Global Transdermal Gel Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transdermal Gel Market Size and Volume Forecast by Type
5.3.1. Ionophoresis
5.3.2. Electroporation
5.3.3. Sonophoresis
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transdermal Gel Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transdermal Gel Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transdermal Gel Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transdermal Gel Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transdermal Gel Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transdermal Gel Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transdermal Gel Demand Share Forecast, 2019-2026
9. North America Transdermal Gel Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transdermal Gel Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transdermal Gel Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transdermal Gel Market Size and Volume Forecast by Type
9.7.1. Ionophoresis
9.7.2. Electroporation
9.7.3. Sonophoresis
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transdermal Gel Demand Share Forecast, 2019-2026
10. Latin America Transdermal Gel Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transdermal Gel Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transdermal Gel Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transdermal Gel Market Size and Volume Forecast by Type
10.7.1. Ionophoresis
10.7.2. Electroporation
10.7.3. Sonophoresis
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transdermal Gel Demand Share Forecast, 2019-2026
11. Europe Transdermal Gel Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transdermal Gel Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transdermal Gel Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transdermal Gel Market Size and Volume Forecast by Type
11.7.1. Ionophoresis
11.7.2. Electroporation
11.7.3. Sonophoresis
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Groth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transdermal Gel Demand Share, 2019-2026
12. Asia Pacific Transdermal Gel Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transdermal Gel Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transdermal Gel Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transdermal Gel Market Size and Volume Forecast by Type
12.7.1. Ionophoresis
12.7.2. Electroporation
12.7.3. Sonophoresis
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transdermal Gel Demand Share, 2019-2026
13. Middle East & Africa Transdermal Gel Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transdermal Gel Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transdermal Gel Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transdermal Gel Market Size and Volume Forecast by Type
13.7.1. Ionophoresis
13.7.2. Electroporation
13.7.3. Sonophoresis
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transdermal Gel Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transdermal Gel Market: Market Share Analysis
14.2. Transdermal Gel Distributors and Customers
14.3. Transdermal Gel Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 3M
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boehringer Ingelheim International
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Mylan
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Norvartis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. GSK
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Novel Pharmaceutical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. LTS Lohmann
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Johson & Johson
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Bayer
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Actavis
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Corium
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook